Navigation Links
Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
Date:12/6/2011

 

The company's Boerne facility houses a progressive manufacturing operation that incorporates many advanced pharmaceutical production technologies.  Production processes are further enhanced through the use of innovative best practices and approaches that ensure both the quality of the products and the most efficient use of resources.  Mission Pharmacal is dedicated to ensuring that its production facilities remain among the most technologically-advanced and environmentally-friendly facilities in the world.

While proud of the legacy and vision of its founder, "to develop and manufacture pharmaceuticals with raw materials of superior quality to ensure the very best and most effective products," Mission Pharmacal looks enthusiastically to the future.  With a number of new drug development efforts in place with current and new service lines, along with plans to expand its partnership efforts with innovative companies both in the United States and overseas, the years ahead promise to be exciting and eventful for the company.  Mission Pharmacal expects to extend its offerings in women's health, urology, pediatrics, and dermatology while adding to its portfolio of consumer nutritional products and introducing new lines as appropriate.

Terry Herring, president of Commercial Operations for Mission Pharmacal, states, "Mission's growth and future continues to rest on our ability as a pharmaceutical company to anticipate and respond to the changing health needs of the world.  Our deep commitment to research and development, matched with our keen interest in providing superior products that meet these changing needs is key to our success."

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patien
'/>"/>

SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Regenicin to Present at Event Celebrating Advancements in Regenerative Medicine
2. MedNet Solutions Achieves the Inc. 5000 List Five Years in a Row
3. Thirty Years After 1st American "Test-Tube Baby," Economy May Be Biggest Obstacle for Infertile Couples
4. Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years
5. InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMDs TCT Satellite Symposium in Washington DC., Today.
6. CAS Chemistry Research Report: 40 Years of Biofuel Research Reveal China Now Atop U.S. in Patenting and Commercialization of Bioethanol
7. $1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years
8. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
9. Lancaster Laboratories -- First Lab to be A2LA Accredited for 30 Consecutive Years
10. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
11. 40 Years on the Leading Edge: Case Western Reserve Universitys Biomedical Engineering Department Commemorates Achievement, Looks to Future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... September 16, 2014 CIRTEC Medical Systems’ ... Highley as CEO of CIRTEC. , “I am ... for the Company.” noted Brian Highley. “The company has ... sustaining strong organic growth over the past two years. ... continuing to improve and expand the services Cirtec offers ...
(Date:9/16/2014)... 16, 2014   Synthetic Biologics, Inc. ... anti-infective biologic and drug programs targeting specific pathogens ... completion of the Company,s Investor Day in ... irritable bowel syndrome (IBS) program, including its novel, ... In the keynote presentation, Mark Pimentel ...
(Date:9/16/2014)... Arizona (PRWEB) September 16, 2014 ... develops safe and effective products to treat patients ... use of a proprietary SPACE™ Technology Platform announced ... and President will present at the White Hat ... at the Hyatt Regency Phoenix. In addition, ...
(Date:9/16/2014)... BARBARA, Calif. , Sept. 16, 2014 /PRNewswire-iReach/ ... Strength index (BMSi) test identifies patients with bone ... cannot.  Over 160 million people worldwide are at ... detected by today,s standard bone strength test, the ... the 2014 American Society for Bone and Mineral ...
Breaking Biology Technology:Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 3Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 2ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 3
... Jan. 4 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ... Annual,JPMorgan Healthcare Conference on Thursday, January 10, 2008 at ... held at the Westin St. Francis,Hotel in San Francisco., ... of Anadys,Pharmaceuticals, Inc., will present an update and overview ...
... 4 ARCA Discovery Inc., a privately held,biopharmaceutical ... other cardiovascular diseases, today announced Richard B.,Brewer, President ... 26th,Annual JPMorgan Healthcare Conference on Tuesday, January 8 ... Conference will be held January 7-10, 2008 at,the ...
... NEW YORK, Jan. 4 QED International ... a series of,20 underlying fund portfolios, today ... on Monday January 7, 2008, Alexion Pharmaceutical, ... Pharmaceutical, Inc. (Nasdaq: ASPV ) in,the ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference 2ARCA Discovery, Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 8, 2008 2QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction 2
(Date:9/16/2014)... tree species has its own bacterial identity. That,s the ... other institutions who studied the genetic fingerprints of bacteria ... island. , "This study demonstrates for the first time ... different ecological strategies possess very different microbial communities on ... former postdoctoral researcher in the UO,s Institute of Ecology ...
(Date:9/16/2014)... A complex web of interaction between viruses, bacteria, ... by a growing international collaboration between Matthew Sullivan, ... of Ecology and Evolutionary Biology and Steven Hallam ... Canada. , "Bacteria are drivers of nutrient ... said. "As the climate is changing, so are ...
(Date:9/16/2014)... extravagant, colorful tail feathers in courtship of a peahen. ... camera developed by an engineer at Washington University in ... choose their mates based on a similar display. , ... used a bioinspired polarization camera developed by Viktor Gruev, ... Washington University, to make the discovery. His camera has ...
Breaking Biology News(10 mins):Microbiome research shows each tree species has a unique bacterial identity 2New research decodes virus-host interactions in ocean dead zones 2New research decodes virus-host interactions in ocean dead zones 3Camera developed at WUSTL sheds light on mate choice of swordtail fish 2
... Nov. 9, 2007 Researchers at Childrens Hospital of ... currently underway to study the effectiveness of oral insulin in ... people at risk for the disease. The researchers want ... or delay the onset of type 1 diabetes in relatives ...
... Flip through the 133 page record of the 2006-2007 activities ... and youll see why they recently took home the nations ... toss fundraiser. Youll find the detailed lesson plans that ... to 75 fifth grades at Spreckels elementary school last year. ...
... helping an effort to eradicate malaria, the mosquito-borne disease ... Researchers at the National Institute of Standards and Technology ... a young company create weakened, harmless versions of the ... to create a new type of vaccine that shows ...
Cached Biology News:Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes 2UC-San Diego Engineering Honor Society wins most outstanding chapter award 2Bug-Zapper: A dose of radiation may help knock out malaria 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: